1-10 of 10
Jaroslaw Czyz
Close
Sort by
Journal Articles

Mass Spectrometry-Based Assessment of M-protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma

Clinical Trials & Observations
Tadeusz Kubicki, Dominik Dytfeld, David R. Barnidge, Dhananjay Sakrikar, Anna Przybyłowicz-Chalecka, Krzysztof Jamroziak, Pawel Robak, Jaroslaw Czyz, Agata Tyczynska, Agnieszka Agata Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Wróbel, Adam Nowicki, Tomasz Szczepaniak, Anna Łojko-Dankowska, Magdalena Matuszak, Lidia Anna Gil, Bartosz Puła, Lukasz Szukalski, Agnieszka Końska, Jan Maciej Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Prof., Ken Jiang, Jennifer Helen Cooperrider, Andrzej J Jakubowiak, Benjamin A. Derman
Journal: Blood
Blood blood.2024024041.
https://doi.org/10.1182/blood.2024024041
Published: 2024
Includes: Supplemental data
Journal Articles

Longitudinal Assessment of Minimal Residual Disease (MRD) in the ATLAS Randomized Phase 3 Trial of Post-Transplant Treatment with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Versus Lenalidomide (R) Alone in Patients with Newly Diagnosed Multiple Myeloma (NDMM)

Tadeusz Kubicki, Dominik Dytfeld, Tomasz Wrobel, Krzysztof Jamroziak, Pawel Robak, Jaroslaw Czyz, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Adam Nowicki, Tomasz Szczepaniak, Anna Lojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Michal Pula, Justyna Rybka, Maciej Majcherek, Lidia Usnarska-Zubkiewicz, Lukasz Szukalski, Agnieszka Konska, Jan M. Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Dorota Kruk-Kwapisz, Oscar Boutros Lahoud, Jeffrey A. Zonder, Kent Griffith, Andrew T Stefka, Ken Jiang, Jennifer H Cooperrider, Ben A Derman, Andrzej J Jakubowiak
Journal: Blood
Blood (2023) 142 (Supplement 1): 4715.
https://doi.org/10.1182/blood-2023-189850
Published: 2023
Journal Articles

Health-Related Quality of Life in Polish Patients with Multiple Myeloma Treated in the Phase 3 ATLAS Trial of Post-Transplant Maintenance with Carfilzomib, Lenalidomide, Dexamethasone or Lenalidomide Alone

Tadeusz Kubicki, Ben A Derman, Krzysztof Jamroziak, Pawel Robak, Jaroslaw Czyz, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Wrobel, Adam Nowicki, Tomasz Szczepaniak, Anna Lojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Michal Pula, Lukasz Szukalski, Agnieszka Konska, Jan M. Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Dorota Kruk-Kwapisz, Andrzej J Jakubowiak, Dominik Dytfeld
Journal: Blood
Blood (2023) 142 (Supplement 1): 3344.
https://doi.org/10.1182/blood-2023-189537
Published: 2023
Journal Articles

Mass Spectrometry-Based Assessment of M-Protein in Peripheral Blood during Maintenance Therapy in Multiple Myeloma (MM) in the Phase III ATLAS Trial

Tadeusz Kubicki, Dominik Dytfeld, David Barnidge, DJ Sakrikar, Gabriella Lakos, Anna Przybylowicz-Chalecka, Krzysztof Jamroziak, Pawel Robak, Jaroslaw Czyz, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Wrobel, Adam Nowicki, Tomasz Szczepaniak, Anna Lojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Michal Pula, Lukasz Szukalski, Agnieszka Konska, Jan M. Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Ken Jiang, Jennifer H Cooperrider, Andrzej J Jakubowiak, Benjamin A Derman
Journal: Blood
Blood (2023) 142 (Supplement 1): 340.
https://doi.org/10.1182/blood-2023-190209
Published: 2023
Journal Articles

Early Mortality in Patients with Multiple Myeloma Treated with Novel Agents - Analysis from Polish Myeloma Study Group

Grzegorz Charlinski, MDPhD, Agata Tyczyńska, MD, Jan M Zaucha, MD PhD, Adriana Czyz, MD, Jarosław Czyż, MDPhD, Dominik Dytfeld, MDPhD, Bartosz Malecki, MD, Lidia Gil, MDPhD, Szymon Fornagiel, MD, Sebastian Grosicki, MD PhD, Agnieszka Barchnicka, MD, Jadwiga Holojda, MD, Agnieszka Kolkowska, MD PhD, Iwona Hus, MD PhD, Grzegorz Helbig, MDPhD, Anna Kopinska, MD, Anna Masternak, MD, Dariusz Woszczyk, MDPhD, Miroslaw Markiewicz, MDPhD, Jaroslaw Piszcz, MDPhD, Janusz Kloczko, MDPhD, Lidia Usnarska-Zubkiewicz, MDPhD, Tomasz Wrobel, MD PhD, Pawel J. Robak, MDPhD, Tadeusz Robak, MDPhD, Anna Waszczuk-Gajda, MD, Grzegorz Basak, MD PhD, Artur Jurczyszyn, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-143003
Published: 2020
Journal Articles

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Clinical Trials & Observations
Constantine S. Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Björn E. Wahlin, Ramón Garcia Sanz, Helen McCarthy, Stephen Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernández de Larrea, David Belada, Edward Libby, Jeffrey V. Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Sunhee Ro, Aileen Cohen, Jane Huang, Meletios Dimopoulos
Journal: Blood
Blood (2020) 136 (18): 2038–2050.
https://doi.org/10.1182/blood.2020006844
Published: 2020
Includes: Supplemental data
Journal Articles

Myeloproliferative Neoplasms in Patients below 25 Years Old at Diagnosis: A Retrospective International Cooperative Work

Ianotto Jean-Christophe, MD PhD, Jean-Jacques Kiladjian, MD PhD, Marta Sobas, MD, Parvis Sadjadian, MD, Lee-Yung Shih, MD, Maria Bieniaszewska, MD, Ilona Seferynska, MDPhD, Mary Frances McMullin, MD, Joanna Waclaw, MD, Laurence Legros, MD PhD, Krzysztof Lewandowski, MD, Mihnea Zdrenghea, MD PhD, Aitor Abuin Blanco, MD, Anna Armatys, MD, Jan Samuelsson, MD PhD, Adrianna Spalek, MD, Anna Angola Figueras, MD, Marie Lauermannova, MD, María-Soledad Noya, MD, Jarosław Czyż, MD, Anna Szmigielska-Kaplon, Rajko Kusec, MD PhD, Joanna Gora Tybor, MD, Anna Masternak, MD, Jan J. Michiels, PhD, Malgorzata Skowronek, MD, Jean-Loup Demory, MD PhD, Katell Le Du, MD, Sonja Zweegman, MD PhD, Carlos Besses Raebel, MD PhD, Stephane Giraudier, MD PhD, Martin Griesshammer, MD PhD, Claire N. Harrison, MD DM, FRCP, PRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 1759.
https://doi.org/10.1182/blood-2018-99-112374
Published: 2018
Journal Articles

Preemptive Daratumumab Therapy for Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple Myeloma: Rationale and Design of the Polish Myeloma Consortium Predator Study

Krzysztof Jamroziak, Krzysztof Giannopoulos, Tomasz Wrobel, MD PhD, Adam Nowicki, Bartosz Pula, Norbert Grząśko, Justyna Rybka, Paweł J. Robak, MD, Agnieszka Druzd-Sitek, Adam Walter-Croneck, Katarzyna Brzeźniakiewicz-Janus, MDPhD, Jarosław Czyż, Krzysztof Warzocha, Dominik Dytfeld
Journal: Blood
Blood (2017) 130 (Supplement 1): 5404.
https://doi.org/10.1182/blood.V130.Suppl_1.5404.5404
Published: 2017
Journal Articles

Impaired Clonogenic Capacity Contributes to Bone Marrow Hypoplasia and Late Hematological Recovery after Zevalin in the Low-Grade NHL Patients.

Wojciech Jurczak, Marta Szostek, Zbigniew Rudzki, Dorota Krochmalczyk, Joanna Wegrzyn, Jaroslaw Czyz, Aleksander B. Skotnicki
Journal: Blood
Blood (2004) 104 (11): 4610.
https://doi.org/10.1182/blood.V104.11.4610.4610
Published: 2004
Journal Articles

Randomized Multicenter Trial of Cladribine Alone (C) or in Combination with Cyclophosphamide (CC), and COP in Previously Untreated Low Grade B-Cell Non-Hodgkin Lymphoma Patients: The First Interim Analysis.

Ewa E. Kalinka, Jaroslaw J. Wajs, Kazimierz Sulek, Tadeusz Robak, Maria Blasinska-Morawiec, Jerzy Holowiecki, Joanna Sawczuk-Chabin, Bernadeta Ceglarek, Lech Konopka, Grzegorz Mazur, Irena Federowicz, Wieslaw Jerdrzejczak, Marzena Watek, Elzbieta Kisiel, Janusz Meder, Piotr Centkowski, Ilona Seferynska, Jaroslaw Czyz, Krzysztof Warzocha, for the Polish Lymphoma Research Group
Journal: Blood
Blood (2004) 104 (11): 3305.
https://doi.org/10.1182/blood.V104.11.3305.3305
Published: 2004